Pregnancy Incidence and Outcomes Among Women Receiving Preexposure Prophylaxis for HIV PreventionNelly Mugo, Jared M. Baeten, Ting Hong et al.|JAMA|2014Cited by 127
Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?Dvora Joseph Davey, Grace M. Aldrovandi, Rachel Baggaley et al.|Journal of the International AIDS Society|2020Cited by 116
The Role of Relationship Dynamics and Gender Inequalities As Barriers to HIV-Serostatus Disclosure: Qualitative Study among Women and Men Living with HIV in Durban, South AfricaDivya S. Bhatia, Lynn T. Matthews|Frontiers in Public Health|2017Cited by 68
BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitroLynn T. Matthews, Irini Sereti, Sherita Chapman et al.|Clinical Immunology|2004Cited by 11